Typically, patients may begin to notice changes in appetite and weight within a few weeks of starting treatment
Endocrine 88(1):8090 Abi Zeid Daou C, Aboul Hosn O, Ghzayel L, Mourad M (2025) Exploring Connections Between Weight-Loss Medications and Thyroid Cancer: A Look at the FDA Adverse Event Reporting System Database
What the drug does to your risk-profile Subcutaneous semaglutide is the only drug in the analysis with high-certainty evidence of reducing the risk of all-cause death (by roughly 19%) and myocardial infarction (by 28%)
These effects typically resolve within one to two weeks of adjusting to the new dose, following the same adaptation pattern you experienced initially
An overall diet high in healthy fats like olive oil (such as the Mediterranean diet) has been shown to lead to better blood sugar control and increased GLP-1 levels compared to a diet high in saturated fats
A muscle-preserving GLP-1 plan should include: Protein at each meal Resistance training at least several days per week when medically appropriate Walking or low-impact movement Hydration and electrolyte support when needed Adequate sleep Monitoring for fatigue or weakness Avoiding overly restrictive dieting Adjusting the medication dose if appetite suppression becomes too strong The goal is not simply to weigh less